Académique Documents
Professionnel Documents
Culture Documents
A transdermal microemulsion-based hydrogel of nisoldipine: preparation, in vitro characterization and in vivo pharmacokinetic evaluation
Yan Xiao, Zhiyi Lin, Jianping Liu*, Wenli Zhang, Ling Wang, Panpan Yu
Department of Pharmaceutics, China Pharmaceutical University, No.24, Tongjiaxiang, Nanjing, China
Received 4 August 2012; Revised 17 October 2012; Accepted 3 December 2012
_____________________________________________________________________________________________________________
Abstract
The purpose of this study was to construct a microemulsion-based hydrogel (MEs-H) for the transdermal delivery of an antihypertensive drug nisoldipine (NS) and to evaluate, predict its in vivo pharmacokinetic behaviors in rats using convolution method. Compositions of the nisoldipine microemulsions (NS-MEs) were determined by simplex lattice mixture design. The nisoldipine microemulsion-based hydrogel (NS-MEs-H) was prepared by adding carbomer. The NS-MEs and NS-MEs-H were characterized by size, morphology and in vitro skin permeation behaviors. In vivo drug plasma concentrations in rats were determined by LC/MS. The drug bioavailability of NS-MEs-H was compared with that of oral suspension. Pharmacokinetic behaviors of NS-MEs-H were predicted by convolution method. The optimized NS-MEs were composed of isopropyl myristate (IPM, 3%, w/w), Cremophor EL (15%, w/w), Transcutol (22%, w/w) and water (60%, w/w). The size of the NS-MEs was 23.12.4 nm and the spherical droplets existed in both NS-MEs and NS-MEs-H. The cumulative amount of NS permeated from NS-MEs and NS-MEs-H were 599.91 49.83 and 461.4738.33 g/cm2 during 72 h, respectively. The pharmacokinetic results showed that transdermal administration of NS-MEs-H could maintain a steady drug plasma concentration in three days. The NS bioavailability of NS-MEs-H was 1.55-fold increased than that of the oral administration. Percent prediction errors of most drug plasma concentrations were below 10%. The NS-MEs-H has the potential to provide a long effective treatment of hypertension, and the convolution method could be utilized to predict in vivo pharmacokinetic behaviors of transdermal drug delivery systems in the preliminary study. Keywords: Transdermal drug delivery; Microemulsion; Pharmacokinetics; Nisoldipine; LC-MS; Convolution ____________________________________________________________________________________________________________
1. Introduction
NS, a calcium antagonist of the 1, 4-dihydropyridine class, can reduce vascular resistance and blood pressure by inhibiting calcium uptake of myocardial and smooth muscle cells. Immediate-release (5 and 10 mg) and controlled-release (10, 20, 30 mg and 40 mg) oral preparations for NS have been approved in a number of countries for the treatment of hypertension and angina pectoris [1-3]. However, absolute bioavailability of the oral tablet is only 5.5%, as a result of significant firstpass metabolism in the gastrointestinal tract and liver [4]. Now many anti-hypertension drugs have been incorporated into the transdermal delivery system [5-6]. Transdermal drug delivery system can avoid the drug degradation in the gastrointestinal tract and the metabolism in the liver, also sustain a steady plasma
__________ *Corresponding author. Address: China Pharmaceutical University, No.24, Tongjiaxiang, Nanjing 210009, China. Tel: +86-25-83271293; Fax: +86-25-83271293 E-mail:jianpingliu1293@163.com
level to decrease side effects particularly those associated with plasma levels fluctuation [7]. However, the outermost layer of skin which mainly consist of stratum corneum forms a main barrier against permeation of drugs, because of its rigid lipid lamellar structure. Thus, methods which can improve skin penetration of active ingredients to achieve therapeutically relevant levels are critical for transdermal formulations. MEs are a dispersion with droplet size from 10 to 100 nm and do not have the tendency to coalesce [8-10]. MEs form spontaneously with appropriate amounts of a lipophilic and a hydrophilic ingredient, as well as a surfactant and a cosurfactant [11]. MEs have several specific physicochemical properties such as transparency, optical isotropy, low viscosity and thermodynamic stability[11-12]. As efficient drug carriers, MEs have been widely employed in both transdermal and dermal delivery of drugs [13-14]. The main mechanisms to explain the advantages of MEs for the transdermal delivery of drugs include the high solubility potential for hydrophilic drugs of ME systems, permeation enhancing effect of the ingredients of MEs, and the increased
1 316 1
thermodynamic activity of the drug in the carriers [9,11-12]. Most of the MEs have very low viscosity, which may restrict their application to the transdermal delivery field due to inconvenient use [15]. The addition of hydrogels, e.g. carrageenan and carbomer, into ME can lead to the formation of hydrogel-thickened ME with a weak gel behavior and the increase of viscosity [16-18]. Several of anti-hypertension drugs have been incorporated in MEs for transdermal delivery [19-20]. In this investigation, NS-MEs-H has been employed to deliver NS transdermally. Usually, it would be cost-consuming and timeconsuming to evaluate in vivo pharmacokinetic behaviors of various formulations, moreover, the in vivo drug plasma concentrations after transdermal administration were hard to detect due to their low concentration. Thus the estimation of in vivo drug concentration by in vitro permeation results was necessary. Convolution method, out of many mathematical approaches, serves as an efficient tool to predict drug plasma concentration based on in vitro data. Through this approach, the in vivo data of various formulations could be calculated and estimated without a lot of experiments in the formulation development stage. In this study, O/W NS-MEs have been developed and optimized using a simplex lattice design. The NS-MEs was incorporated into Carbopol 980 to form a NS-MEs-H. The NS-MEs and NS-MEs-H were characterized by size, morphology and in vitro skin permeation studies. In vivo pharmacokinetic behaviors after transdermal administration of NS-MEs-H were estimated. The drug plasma concentration in rats was predicted using a convolution method and the prediction ability was also evaluated.
chromatographymass spectrometry (LC/MS) grade. All other chemicals and reagents were of analytical grade. Male Sprague-Dawley rats (180200 g and 220 250 g) were obtained from the animal centre of China Pharmaceutical University (Nanjing, China). All animal experiments were approved by the Institutional Animal Care and Use Committee of China Pharmaceutical University. 2.2. HPLC analysis of NS in vitro The concentrations of NS in the samples were analyzed by HPLC (Shimadzu LC-10A, Kyoto, Japan). NS was separated by a reversed phase C18 column (5 m, 4.6 mm250 mm, Kromasil) and detected using UV detection at a wave length of 237nm. A 80:20 (v/v) mixture of methanol and water was used as mobile phase with a flow rate of 1 ml/min. The column temperature was 40C and the injection volume was 20 l. The peak area correlated linearly with NS concentration in the range of 0.550.0 g/ml with the lowest detection limit at 0.5 g/ml, and the mean correlation coefficient was 0.9998. 2.3. Screening of components for MEs To find out appropriate components that have good solubilizing capacity of NS, the solubility of NS in different oils, surfactants and cosurfactants were determined. Oils employed were Labrafil M 1944, olive oil, oleic acid and IPM. Cremophor EL and Tween 80 were chosen as surfactants. Cosurfactants selected were Transcutol and PEG400. An excess amount of NS was added to 2 ml of each excipient and turbine reciprocally at 32C, then shook at 32C for 72 h. Samples were centrifuged at 10,000 rpm for 10 minutes. The supernatant was separated and then diluted with ethanol. The diluted samples were filtered through 0.45 m membrane filter and solubility of NS was determined by HPLC. 2.4. Pseudo-ternary phase diagrams To determine the concentration of components for the existing range of the ME, the pseudo-ternary phase diagrams were constructed using water titration method. Different phase diagrams were prepared with the 1:4, 1:2, 1:1 and 2:1 weight ratio of surfactant to cosurfactant. For each phase diagram, the ratios of oil to the mixture of surfactant and cosurfactant were varied as 9:1, 8:2, 7:3, 6:4, 5:5, 4:6, 3:7, 2:8 and 1:9 (w/w). Water was added drop by drop under gentle magnetic stirring at 32C. After equilibration, the mixtures were assessed visually under light versus a dark background and determined as being MEs by their clarity and transparency.
1 317 1
2.5. Preparation of NS-MEs NS-MEs were prepared by dissolving 0.4% (w/w) NS in the mixture of oil, surfactant and cosurfactant, then water was added drop by drop with the help of gentle magnetic stirring at 32C and the final preparation was made up to 100% (w/w). The MEs were sealed tightly and stored at ambient temperature. 2.6. In vitro permeation studies Male Sprague-Dawley rats weighing 180200 g were sacrificed using an anesthetic ether. After hair was removed carefully with a razor, the full thickness abdominal skin was cautiously excised and the subcutaneous tissues were trimmed. Before use, the skins were washed with water and examined for their integrity. If not used immediately, the skin was always kept in refrigerator (04C) and limited to be used within 3 days. The rat abdominal skin was mounted onto a modified Franz diffusion cell with the stratum corneum facing the donor cell and the in vitro transdermal permeation behaviors of the drug from the NS-MEs were investigated. The receptor volume was 17 ml and the area of diffusion was 2.92 cm2. Before the permeation experiment, the receptor cell was filled with normal saline containing 20% ethanol as the receiver medium. The receptor media was maintained at 320.5C and magnetically stirred at 250 rpm. The ME formulation was applied on the stratum corneum (0.5 g/cm2, the NS concentration in ME was 4 mg/g) by gently pipetting the solution into the donor cell. At the time points 2.0, 4.0, 6.0, 8.0, 10.0, 12.0, 24.0, 36.0, 48.0, 60.0, and 72.0 h, 5 ml of the receptor media was taken and then replaced with the same amount of the fresh receptor medium. The permeation samples were filtered through 0.45 m filter films and analyzed by HPLC. The cumulative amount of permeated drug per unit area of skin (Q, g/cm2) at time point n was calculated using Eq. (1).
Qn Cn V
Drug solubility in different ME formulations was measured according to the method described in the section of Screening of components for MEs. 2.8. Formulation optimization The component proportion of MEs was optimized by using the simplex lattice experiment design [21-22]. In this research, the concentration of surfactant, cosurfactant and water, were selected as independent variables. Two critical values for evaluation of the transdermal MEs-H, the cumulative amount of NS permeated through excised rat skins per unit area and the drug solubility in the MEs, were taken as responses. As shown in Fig. 1, the simplex lattice design for a three factor system can be represented as an equilateral triangle with seven points on it. A, B and C represent three formulations containing the maximum amount of one component; with the other two components has the minimum concentration. Other three points located at the halfway points between vertices (AB, BC, and AC) represent three formulations containing the average of the minimum and maximum amounts of the two components. The last one is at the center point (ABC) represents a formulation containing one third of each component. The concentrations of those three factors change simultaneously but always keep their total concentration constant. Seven ME formulations were prepared based on the rules. The responses for them were used to fit an equation to predict each response values of all possible MEs [23].